Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.

about

Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.

P2860

Q48344360-C28BA0A2-EA17-4767-8F8F-DC858A4454EA

P2860

Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.

Item

http://www.wikidata.org/entity/Q48665122

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Development of a transplantabl ...... MRI/MRS/MRSI characterisation.

@en

Development of a transplantabl ...... MRI/MRS/MRSI characterisation.

@nl

type

Item

label

Development of a transplantabl ...... MRI/MRS/MRSI characterisation.

@en

Development of a transplantabl ...... MRI/MRS/MRSI characterisation.

@nl

prefLabel

Development of a transplantabl ...... MRI/MRS/MRSI characterisation.

@en

Development of a transplantabl ...... MRI/MRS/MRSI characterisation.

@nl

P1476

Development of a transplantabl ...... MRI/MRS/MRSI characterisation.

@en

P2093

Cristina Herranz

http://www.w3.org/2001/XMLSchema#string

Magdalena Ciezka

http://www.w3.org/2001/XMLSchema#string

Martí Pumarola

http://www.w3.org/2001/XMLSchema#string

Milena Acosta

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

MR imaging features of high-grade gliomas in murine models: how they compare with human disease, reflect tumor biology, and play a role in preclinical trials

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI.

The clinical value of proton magnetic resonance spectroscopy in adult brain tumours.

In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI.

Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Ca

Multimodality assessment of brain tumors and tumor recurrence.

P2888

s11060-016-2164-3

P304

67-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-016-2164-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Josep M. Canals

Carles Arús

Ana P Candiota

P577

2016-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27324642

http://www.w3.org/2001/XMLSchema#string

Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.

about

P2860

P2860

Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698